Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Furin

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2013
Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011M Gegia, H E Jenkins, I Kalandadze, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 6, 2013
Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case studyJ Furin, G Brigden, E Lessem, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2014
'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIVJ Furin, P Isaakidis, A J Reid, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009M Gegia, T Cohen, I Kalandadze, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2015
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerationsR Taneja, A J Garcia-Prats, J Furin, et al.
BMC Infectious Diseases|July 17, 2023
What clinic closure reveals about care for drug-resistant TB: a qualitative studyThiloshini Govender, Jennifer J Furin, Alex Edwards, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 6, 2003
The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)E Palacios, D Guerra, K Llaro, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
QTc prolongation and treatment of multidrug-resistant tuberculosisE Harausz, H Cox, M Rich, et al.
Global Pediatric Health|November 10, 2016
Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, PeruDylan B Tierney, Meredith B Milstein, Justin Manjourides, et al.
Infectious Disease Clinics of North America|October 4, 2020
Drug-Resistant Tuberculosis: A Glance at Progress and Global ChallengesKhalid M Dousa, Sebastian G Kurz, Charles M Bark, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2013
Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011M Gegia, H E Jenkins, I Kalandadze, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 6, 2013
Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case studyJ Furin, G Brigden, E Lessem, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2014
'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIVJ Furin, P Isaakidis, A J Reid, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009M Gegia, T Cohen, I Kalandadze, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2015
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerationsR Taneja, A J Garcia-Prats, J Furin, et al.
BMC Infectious Diseases|July 17, 2023
What clinic closure reveals about care for drug-resistant TB: a qualitative studyThiloshini Govender, Jennifer J Furin, Alex Edwards, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 6, 2003
The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)E Palacios, D Guerra, K Llaro, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
QTc prolongation and treatment of multidrug-resistant tuberculosisE Harausz, H Cox, M Rich, et al.
Global Pediatric Health|November 10, 2016
Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, PeruDylan B Tierney, Meredith B Milstein, Justin Manjourides, et al.
Infectious Disease Clinics of North America|October 4, 2020
Drug-Resistant Tuberculosis: A Glance at Progress and Global ChallengesKhalid M Dousa, Sebastian G Kurz, Charles M Bark, et al.
Pageof 9